Tal Zvi Zaks, Director at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 17 shares at $34.87 ($593) on 2026-08-05, disclosed to the SEC on 2026-08-10.
Open-market sale of $593 TEVA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| MRNA | SELL | 2021-06-21 | $1.0M | — | Filing → |
| MRNA | SELL | 2021-06-11 | $1.1M | — | Filing → |
| MRNA | SELL | 2021-06-03 | $920K | — | Filing → |